# Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Chronic Lymphocytic Leukemia

> **NCT00002838** · PHASE1,PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 13 (actual)

## Conditions studied

- Leukemia

## Interventions

- **BIOLOGICAL:** Filgrastim (G-CSF)
- **DRUG:** Cyclophosphamide
- **DRUG:** Fludarabine Phosphate
- **PROCEDURE:** Peripheral Blood Stem Cell Transplantation

## Key facts

- **NCT ID:** NCT00002838
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-12
- **Primary completion:** 2002-07
- **Final completion:** 2002-07
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2012-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002838, "Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Chronic Lymphocytic Leukemia". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00002838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*